Martín-Villalba, A., & Krammer, P. H. (2002). Inhibition of TNF and CD95(APO-1/Fas) ligand as a novel therapy for stroke. Emirates medical journal, 20, .
Chicago Style (17th ed.) CitationMartín-Villalba, Ana, and Peter H. Krammer. "Inhibition of TNF and CD95(APO-1/Fas) Ligand as a Novel Therapy for Stroke." Emirates Medical Journal 20 (2002).
MLA (9th ed.) CitationMartín-Villalba, Ana, and Peter H. Krammer. "Inhibition of TNF and CD95(APO-1/Fas) Ligand as a Novel Therapy for Stroke." Emirates Medical Journal, vol. 20, 2002.
Warning: These citations may not always be 100% accurate.